Literature DB >> 7885041

The spontaneous expression of interleukin-1 beta and interleukin-6 is associated with spontaneous expression of AP-1 and NF-kappa B transcription factor in acute myeloblastic leukemia cells.

W H Dokter1, L Tuyt, S J Sierdsema, M T Esselink, E Vellenga.   

Abstract

The nature of the spontaneous expression of cytokines that is observed in blasts of some AML patients is unclear. We studied whether or not the spontaneous expression of IL-1 beta and IL-6 is due to an increased transcription rate of the cytokine gene and associated with a spontaneous expression of two transcription factors that play an important role in IL-1 beta and IL-6 gene transcription, namely activator protein-1 (AP-1) and nuclear factor-kappa B (NF-kappa B). In eight of the 19 AML patients a spontaneous expression of IL-1 beta mRNA was observed, whereas IL-6 mRNA was expressed in seven of the cases. Expression of IL-6 mRNA correlated nicely with the secretion of IL-6 protein. Nuclear run-on experiments showed that spontaneous expression of IL-1 beta and IL-6 was at least partly due to an increased transcription rate of the respective genes compared to the results from healthy unstimulated monocytes. Electrophoretic mobility shift assays demonstrated that especially spontaneous expression of NF-kappa B is associated with spontaneous cytokine expression. However, the spontaneous expression of transcription factors is not due to the endogenous secretion of IL-1 since the addition of anti-IL-1 monoclonal antibody did not affect the expression of NF-kappa B. Finally, supershift experiments were performed that demonstrated that the NF-kappa B consists of the p50 and the p65 subunits. In summary, these results demonstrate that the spontaneous expression of cytokines is frequently associated with an increased transcription rate and a spontaneous expression of transcription factors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7885041

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  12 in total

1.  Deoxyribonucleic acid triplex formation inhibits granulocyte macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cells.

Authors:  M Kochetkova; P O Iversen; A F Lopez; M F Shannon
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

2.  EphB1 Suppression in Acute Myelogenous Leukemia: Regulating the DNA Damage Control System.

Authors:  K R Kampen; F J G Scherpen; G Garcia-Manero; H Yang; G J L Kaspers; J Cloos; C M Zwaan; M M van den Heuvel-Eibrink; S M Kornblau; E S J M De Bont
Journal:  Mol Cancer Res       Date:  2015-05-05       Impact factor: 5.852

3.  The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.

Authors:  K U Birkenkamp; L M Tuyt; C Lummen; A T Wierenga; W Kruijer; E Vellenga
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

4.  Inhibition of the transforming growth factor beta (TGFbeta) pathway by interleukin-1beta is mediated through TGFbeta-activated kinase 1 phosphorylation of SMAD3.

Authors:  Germaine F J D Benus; Albertus T J Wierenga; David J J de Gorter; Jan Jacob Schuringa; Ariëtte M van Bennekum; Loes Drenth-Diephuis; Edo Vellenga; Bart J L Eggen
Journal:  Mol Biol Cell       Date:  2005-05-25       Impact factor: 4.138

5.  Insights in dynamic kinome reprogramming as a consequence of MEK inhibition in MLL-rearranged AML.

Authors:  K R Kampen; A Ter Elst; H Mahmud; F J G Scherpen; S H Diks; M P Peppelenbosch; V de Haas; V Guryev; E S J M de Bont
Journal:  Leukemia       Date:  2013-11-18       Impact factor: 11.528

6.  Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis.

Authors:  Ivan Topisirovic; Monica L Guzman; Melanie J McConnell; Jonathan D Licht; Biljana Culjkovic; Sarah J Neering; Craig T Jordan; Katherine L B Borden
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

7.  De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes.

Authors:  Matheus Rodrigues Lopes; João Kleber Novais Pereira; Paula de Melo Campos; João Agostinho Machado-Neto; Fabiola Traina; Sara T Olalla Saad; Patricia Favaro
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

8.  Effect of IKZF1 deletions on signal transduction pathways in Philadelphia chromosome negative pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL).

Authors:  Naomi E van der Sligte; Frank J G Scherpen; Arja Ter Elst; Victor Guryev; Frank N van Leeuwen; Eveline S J M de Bont
Journal:  Exp Hematol Oncol       Date:  2015-08-12

9.  A computational model of lipopolysaccharide-induced nuclear factor kappa B activation: a key signalling pathway in infection-induced preterm labour.

Authors:  Gemma C Sharp; Hongwu Ma; Philippa T K Saunders; Jane E Norman
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

Review 10.  NF-κB in Hematological Malignancies.

Authors:  Véronique Imbert; Jean-François Peyron
Journal:  Biomedicines       Date:  2017-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.